ULTIBRO BREEZHALER is indicated as once -daily maintenance bronchodilator treatment to relieve symptoms and reduce exacerbations in patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are still symptomatic despite treatment with indacaterol alone or glycopyrronium alone or the combination of salmeterol/fluticasone.
ULTIBRO BREEZHALER is indicated as once-daily maintenance bronchodilator treatment to relieve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are still symptomatic despite treatment with tiotropium alone.
Other Services
Country
Account